|
|
Article: Eisai Debuts Newly Expanded Facility; Company's rapid growth spurs expansion of facility to accommodate increased production and pharmaceutical R&D activities.
- Article from:
- Business Wire
- Article date:
- May 9, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
RESEARCH TRIANGLE PARK, NC--(BUSINESS WIRE)--May 9, 2001
Eisai Inc., responsible for developing medicines for Alzheimer's disease and certain gastrointestinal disorders, is also producing benefits for the Research Triangle Park (RTP) community. Local and international dignitaries gathered here today to dedicate Eisai Inc.'s expansion of its RTP facility to accommodate the fast-growing company's needs for additional space for production, administration and pharmaceutical research and development. Eisai Inc. is the U.S. pharmaceutical operation of Eisai Co., Ltd. of Tokyo, Japan.
The expansion adds 24,000 square feet to the Eisai ...
Related newspaper, magazine, and journal articles:
|
|
Article: Eisai Inc. Assumes U.S. Distribution Responsibilities for ...
PR Newswire;
January 7, 2004 ;
700+ words
... ... discovered and developed by Eisai and is manufactured and packaged in its Research Triangle Park, N.C., facility ... of Aciphex(R) to Eisai marks the accomplishment ... facility in Research Triangle Park, N.C., and in the ... Between 1998 and 2002, Eisai Inc. moved up rapidly ...
|
|